Vista Pharmaceuticals hits 10% upper circuit

The company already filed a complex ANDA in September 2017, targeting Cardiology segment with a market size of $200 million (Rs1,360cr) as per latest IMS data.

from India Infoline News Service https://ift.tt/2xl9kbH

Comments

Popular posts from this blog

What are the key measures of market volatility?

https://ift.tt/2IVHF6y